Accutane
$ 40,00 – $ 650,00Price range: $ 40,00 through $ 650,00
Aciclovir
$ 44,00 – $ 232,00Price range: $ 44,00 through $ 232,00
Aceon
$ 51,00 – $ 491,00Price range: $ 51,00 through $ 491,00
Aceon is a highly effective ACE inhibitor primarily used to manage and treat high blood pressure. By helping to relax blood vessels, this medication ensures that blood flows more easily throughout the body. It is also indicated for patients with stable coronary artery disease to reduce the risk of heart attack or cardiovascular death. The active ingredient works efficiently to decrease the overall workload on the heart muscle. Incorporating Aceon into a daily routine helps maintain healthy blood pressure levels and supports long-term cardiovascular wellness.
Active substance: erbumine, perindopril
SKU:
Aceon
Category: Blood Pressure
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Aceon belongs to a class of cardiovascular medications known as angiotensin-converting enzyme (ACE) inhibitors. It contains perindopril erbumine as its active pharmaceutical ingredient and is approved by the U.S. Food and Drug Administration (FDA) for the treatment of essential hypertension and the reduction of cardiovascular risk in patients with stable coronary artery disease.
Dispensed strictly as a prescription-only therapy (Rx), Aceon exerts its therapeutic effects by modulating the renin-angiotensin-aldosterone system. Clinical management with this agent requires periodic laboratory evaluation and individualized dosing under the supervision of a licensed healthcare provider.
| Parameter | Details |
|---|---|
| Drug name | Aceon |
| Active ingredient | Perindopril erbumine |
| Therapeutic class | ACE inhibitor (Antihypertensive / Cardiovascular agent) |
| Dosage form | Oral tablet (2 mg, 4 mg, 8 mg) |
| Route of administration | Oral |
| Prescription status | Prescription (Rx) only |
| Primary purpose | Management of essential hypertension and risk reduction in stable coronary artery disease |
Key Clinical Characteristics
How the drug works: Aceon is an inactive prodrug that undergoes hepatic hydrolysis to form its active metabolite, perindoprilat. Perindoprilat inhibits angiotensin-converting enzyme, which is responsible for catalyzing the conversion of angiotensin I to angiotensin II. Angiotensin II is a potent endogenous vasoconstrictor that also stimulates aldosterone secretion by the adrenal cortex.
By blocking angiotensin II formation, Aceon induces systemic vasodilation, decreases peripheral vascular resistance, and lowers arterial blood pressure. Additionally, inhibition of ACE prevents the breakdown of bradykinin, a vasodilatory peptide, contributing to the overall blood pressure-lowering effect. These physiological changes lead to decreased workload on the heart and reduced arterial wall stiffness.
What it’s used for: Aceon is indicated for two main FDA-approved clinical uses in adult populations. First, it is used for the management of essential hypertension, either as monotherapy or in combination with other antihypertensive drug classes, such as thiazide diuretics. Lowering elevated blood pressure decreases the risk of fatal and nonfatal cardiovascular events, primarily strokes and heart attacks.
Second, Aceon is indicated in patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or nonfatal myocardial infarction. Any use outside of these specified parameters–such as managing diabetic nephropathy or heart failure without established coronary artery disease–is considered an off-label application and must be clinically evaluated on an individual basis by a qualified prescriber.
Dosing schedule: Aceon is supplied in oral tablet strengths of 2 mg, 4 mg, and 8 mg of perindopril erbumine. For the management of hypertension, the recommended initial starting dose in adults is 4 mg administered once daily. Based on clinical response and blood pressure control, the dosage may be titrated up to a maximum of 8 mg once daily. In patients already receiving diuretic therapy, initial dosing is often started under close medical supervision to prevent acute hypotension.
For patients with stable coronary artery disease, the target dosage is 8 mg once daily, typically initiated at 4 mg once daily for the first 2 weeks before titrating upward as tolerated. Dosage adjustments are required in individuals with impaired renal function, specifically those with a creatinine clearance below 60 mL/min.
How it’s absorbed and eliminated: Following oral administration, Aceon is rapidly absorbed from the gastrointestinal tract, reaching peak plasma concentrations of perindopril within approximately 1 hour. Absolute bioavailability of perindopril is approximately 24%. Extensively metabolized in the liver, approximately 20% of the absorbed dose is converted into the active diacid metabolite, perindoprilat.
Peak plasma levels of perindoprilat occur between 3 and 7 hours post-dose. While the plasma elimination half-life of unchanged perindopril is roughly 0.8 to 1 hour, perindoprilat exhibits a complex elimination profile. The prolonged effective elimination half-life of perindoprilat is approximately 30 to 120 hours, reflecting its strong binding affinity to plasma and tissue angiotensin-converting enzyme. Elimination occurs primarily via renal excretion.
What to avoid while taking it: Concomitant intake of food slightly decreases the extent of conversion to perindoprilat, though Aceon may generally be administered without regard to meals. Patients should avoid potassium supplements or salt substitutes containing potassium without explicit medical authorization, as ACE inhibition reduces aldosterone secretion and can precipitate elevated serum potassium levels. Alcohol consumption should be minimized, as ethanol can potentiate the blood pressure-lowering effect of Aceon, increasing the risk of orthostatic dizziness or syncope.
Compatibility with other medicines: Co-administration of Aceon with potassium-sparing diuretics (such as spironolactone, triamterene, or amiloride) or potassium supplements significantly increases the risk of hyperkalemia. Concurrent use of nonsteroidal anti-inflammatory drugs (NSAIDs), including selective COX-2 inhibitors, may attenuate the antihypertensive efficacy of Aceon and accelerate deterioration of renal function, particularly in elderly or volume-depleted individuals.
Combining Aceon with lithium can lead to increased serum lithium concentrations and lithium toxicity. Simultaneous blockade of the renin-angiotensin system with angiotensin receptor blockers (ARBs) or direct renin inhibitors like aliskiren is generally avoided due to heightened risks of severe hypotension, hyperkalemia, and acute kidney injury. Nitritoid reactions (flushing, nausea, vomiting, hypotension) have been reported rarely in patients receiving injectable gold (sodium aurothiomalate) concurrently with ACE inhibitor therapy.
Safety Information and Patient Guidance
Adverse reactions: The adverse event profile of Aceon is consistent with that of the ACE inhibitor class. A persistent, non-productive dry cough is a documented adverse reaction, resulting from decreased bradykinin degradation; this cough resolves only upon treatment discontinuation. Commonly reported side effects in clinical trials include dizziness, headache, fatigue, back pain, and upper respiratory tract infections.
Gastrointestinal side effects such as diarrhea, nausea, and abdominal pain may also occur. Less common but clinically significant reactions include symptomatic hypotension, particularly following initial dosing or dosage escalation in volume-depleted patients. Laboratory changes can include mild increases in blood urea nitrogen (BUN), serum creatinine, and serum potassium.
Important precautions: Aceon carries a boxed warning regarding fetal toxicity. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus when administered during the second and third trimesters of pregnancy. When pregnancy is detected, Aceon must be discontinued as soon as possible.
Angioedema of the face, extremities, lips, tongue, glottis, or larynx has been reported with ACE inhibitors. If laryngeal stridor or angioedema of the face, tongue, or glottis occurs, administration must be stopped immediately and appropriate emergency treatment provided. Head and neck angioedema can cause fatal airway obstruction. Aceon is contraindicated in patients with a history of angioedema related to previous ACE inhibitor treatment or hereditary/idiopathic angioedema. Caution is required in geriatric populations, individuals with severe renal impairment, renal artery stenosis, or severe heart failure.
If you skip a dose: If a scheduled dose of Aceon is missed, it should be taken as soon as remembered on the same day. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely, and the regular dosing schedule resumed. Patients should not double the dose to compensate for a missed tablet, as this increases the risk of excessive hypotension.
Red flags: Urgent medical evaluation is necessary if specific severe symptoms develop while taking Aceon. Immediate emergency medical assistance should be sought if signs of angioedema appear, including swelling of the face, lips, tongue, or throat, or severe difficulty breathing or swallowing. Sudden severe dizziness, lightheadedness, or fainting (syncope) indicates potentially severe hypotension. Unexplained jaundice, severe abdominal pain, or signs of high potassium (such as muscle weakness or irregular heartbeat) also require prompt clinical attention.
Storage and expiration: Aceon tablets should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). The medication must be kept in a tightly closed container, protected from moisture and excessive heat. Do not use Aceon past the expiration date printed on the packaging. Keep out of reach of children.
Common questions:
How long does it take for Aceon to lower blood pressure?
Initial blood pressure reduction is typically observed within 1 to 2 hours following oral administration of Aceon, with peak antihypertensive effect achieved at approximately 4 to 6 hours. However, maximum therapeutic blood pressure reduction may require up to 4 weeks of continuous daily administration.
What should be done if a dry cough develops while taking Aceon?
A persistent, dry, non-productive cough is a known pharmacological effect of ACE inhibitors. Over-the-counter cough suppressants are generally ineffective for this symptom. Patients experiencing a bothersome cough should consult their prescribing clinician, who may consider switching therapy to an alternative drug class such as an angiotensin II receptor blocker (ARB).
Is routine blood testing required during Aceon therapy?
Yes. Periodic laboratory monitoring of renal function (serum creatinine and blood urea nitrogen) and serum potassium levels is recommended, particularly after starting treatment, increasing the dose, or in patients with underlying kidney disease or diabetes.
Can Aceon be taken during pregnancy or while breastfeeding?
Aceon is strictly contraindicated during pregnancy due to the risk of fetal harm, acute kidney impairment, and fetal death. Data regarding secretion of perindopril into human milk are limited; alternative therapies are usually preferred during breastfeeding after clinical risk-benefit evaluation by a healthcare professional.
Information aligned with U.S. Food and Drug Administration (FDA) prescribing documentation.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
2mg ,4mg ,8mg |
|---|---|
| Package |
30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία | , |
Related products
Aldactone
$ 33,00 – $ 345,00Price range: $ 33,00 through $ 345,00
Active substance: Spironolactone
More Details
This product has multiple variants. The options may be chosen on the product page
Calan
$ 46,00 – $ 242,00Price range: $ 46,00 through $ 242,00
Active substance: Verapamil
More Details
This product has multiple variants. The options may be chosen on the product page
Capoten
$ 42,00 – $ 323,00Price range: $ 42,00 through $ 323,00
Active substance: Captopril
More Details
This product has multiple variants. The options may be chosen on the product page
Coreg
$ 41,00 – $ 651,00Price range: $ 41,00 through $ 651,00
Active substance: Carvedilol
More Details
This product has multiple variants. The options may be chosen on the product page
Digoxin
$ 48,00 – $ 152,00Price range: $ 48,00 through $ 152,00
Active substance: digoxin
More Details
This product has multiple variants. The options may be chosen on the product page
Diltiazem
$ 49,00 – $ 590,00Price range: $ 49,00 through $ 590,00
Active substance: Diltiazem
More Details
This product has multiple variants. The options may be chosen on the product page
Diltiazem HCL
$ 52,00 – $ 393,00Price range: $ 52,00 through $ 393,00
Active substance: Diltiazem
More Details
This product has multiple variants. The options may be chosen on the product page
Doxazosin
$ 42,00 – $ 332,00Price range: $ 42,00 through $ 332,00
Active substance: Doxazosin
More Details
This product has multiple variants. The options may be chosen on the product page
